Poole Robert Michael 4
4 · Ovid Therapeutics Inc. · Filed Jul 13, 2021
Insider Transaction Report
Form 4
Poole Robert Michael
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-07-09+30,000→ 30,000 totalExercise: $3.94Exp: 2031-07-08→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option shall vest as follows: 1/36th of the shares subject to the option shall vest every month after July 9, 2021, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2017 Equity Incentive Plan) on each vesting date.